Published May 1, 2021 | Version v1
Journal article

Reversing the cytotoxicity of uric acid by supramolecular encapsulation with acyclic cucurbit[n]uril

  • 1. Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500 (China)
  • 2. Yunnan Perrrin Technology Co. Ltd., Kunming 650201 (China)
  • 3. Faculty of Chemical Engineering, Kunming University of Science and Technology, Kunming 650500 (China)

Description

Supramolecular encapsulation, which removes harmful substances from organisms, has evolved into a new strategy. In this paper, three supramolecular complexes of acyclic cucurbit[n]urils (ACBs) with uric acid (UA) were prepared, and the inclusion behavior of ACBs and UA was studied by fluorescence spectroscopy, UV–vis spectroscopy and nuclear magnetic resonance. Furthermore, the effect of the complexes of UA with ACBs on the expression of inflammatory biomarkers in human hepatoma HepG2 cell lines was characterized through C-reactive protein (CRP) western blot. The results showed UA molecules can be recognized by three ACBs with different binding constants, and ACBs successfully blocked the inflammatory stimulation of UA on HepG2 cell lines and inhibited the expression of the major inflammatory factor CRP by the formation of complexes between UA and ACBs. This article proves that ACBs can efficiently reverse the cytotoxicity of UA, which provides a new method for treating hyperuricemia disease. (paper)

Availability note (English)

Available from http://dx.doi.org/10.1088/1748-605X/abcf04

Additional details

Identifiers

Publishing Information

Journal Title
Biomedical Materials (Bristol. Online)
Journal Volume
16
Journal Issue
3
Journal Page Range
[11 p.]
ISSN
1748-605X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53053313
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
BIOLOGICAL MARKERS; GLOBULINS; HEPATOMAS; INFLAMMATION; URIC ACID
Descriptors DEC
AROMATICS; AZAARENES; CARCINOMAS; DISEASES; HETEROCYCLIC COMPOUNDS; HYDROCARBONS; NEOPLASMS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; PATHOLOGICAL CHANGES; PROTEINS; PURINES; SYMPTOMS; XANTHINES